James Xue
Chief Executive Officer at CANBRIDGE PHARMACEUTICALS INC.
Net worth: 2 M $ as of 30/05/2024
James Xue active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Chief Executive Officer | 29/01/2018 | - |
| Chairman | 29/01/2018 | - | |
| Founder | 29/01/2018 | - | |
CANbridge Life Sciences Ltd.
 CANbridge Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology CANbridge Life Sciences Ltd. produces biopharmaceutical products. It engages in the research and development of therapeutic drug treatment for critical medical condition. The company was founded by James Xue on June 12, 2012 and is headquartered in Chaoyang, China. | Chief Executive Officer | 11/06/2012 | - |
| Chairman | 11/06/2012 | - | |
| Founder | 11/06/2012 | - | |
| President | 11/06/2012 | - | |
| CANbridge Consulting LLC | Founder | - | - |
| President | - | - | |
Canbridge Pharmaceuticals, Inc. (United States)
 Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Director/Board Member | - | - |
| President | - | - | |
| Corporate Secretary | - | - | |
| China Alliance For Rare Diseases | Corporate Officer/Principal | - | - |
| Shanghai Foundation For Rare Disease | Corporate Officer/Principal | - | - |
| University of Michigan Medical School | Corporate Officer/Principal | 31/07/2017 | - |
| Peking University Health Science Center | Corporate Officer/Principal | 31/07/2017 | - |
| The BayHelix Group | Corporate Officer/Principal | - | - |
Career history of James Xue
Former positions of James Xue
| Companies | Position | Start | End |
|---|---|---|---|
| ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of James Xue
| Brown University | Doctorate Degree |
| University of California | Graduate Degree |
| University of Virginia Darden School of Business | Masters Business Admin |
| Peking University School of Pharmaceutical Sciences | Undergraduate Degree |
Statistics
International
| United States | 9 |
| China | 7 |
Operational
| Corporate Officer/Principal | 6 |
| Founder | 3 |
| President | 3 |
Sectoral
| Consumer Services | 7 |
| Health Technology | 5 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Health Technology |
| Private companies | 7 |
|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| The BayHelix Group | |
CANbridge Life Sciences Ltd.
CANbridge Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology CANbridge Life Sciences Ltd. produces biopharmaceutical products. It engages in the research and development of therapeutic drug treatment for critical medical condition. The company was founded by James Xue on June 12, 2012 and is headquartered in Chaoyang, China. | Health Technology |
| CANbridge Consulting LLC | |
Canbridge Pharmaceuticals, Inc. (United States)
Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Health Technology |
| China Alliance For Rare Diseases | |
| Shanghai Foundation For Rare Disease |
- Stock Market
- Insiders
- James Xue
- Experience